Literature DB >> 17919942

Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells.

Astrid J van Beelen1, Zuzana Zelinkova, Esther W Taanman-Kueter, Femke J Muller, Daniel W Hommes, Sebastian A J Zaat, Martien L Kapsenberg, Esther C de Jong.   

Abstract

How the development of antibacterial T helper 17 (Th17) cells is selectively promoted by antigen-presenting dendritic cells (DCs) is unclear. We showed that bacteria, but not viruses, primed human DCs to promote IL-17 production in memory Th cells through the nucleotide oligomerization domain 2 (NOD2)-ligand muramyldipeptide (MDP), a derivative of bacterial peptidoglycan. MDP enhanced obligate bacterial Toll-like receptor (TLR) agonist induction of IL-23 and IL-1, which promoted IL-17 expression in T cells. The role of NOD2 in this IL-23-IL-1-IL-17 axis could be confirmed in NOD2-deficient DCs, such as DCs from selected Crohn's disease patients. Thus, antibacterial Th17-mediated immunity in humans is orchestrated by DCs upon sensing bacterial NOD2-ligand MDP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919942     DOI: 10.1016/j.immuni.2007.08.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  214 in total

Review 1.  Regulation of TH17 cell differentiation by innate immune signals.

Authors:  Gonghua Huang; Yanyan Wang; Hongbo Chi
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  The pathogenic Th17 cell response to major schistosome egg antigen is sequentially dependent on IL-23 and IL-1β.

Authors:  Mara G Shainheit; Krzysztof W Lasocki; Eduardo Finger; Bridget M Larkin; Patrick M Smith; Arlene H Sharpe; Charles A Dinarello; Laura I Rutitzky; Miguel J Stadecker
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

3.  Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax.

Authors:  Sandip K Datta; Mojgan Sabet; Kim Phung L Nguyen; Patricia A Valdez; Jose M Gonzalez-Navajas; Shamima Islam; Ivan Mihajlov; Joshua Fierer; Paul A Insel; Nicholas J Webster; Donald G Guiney; Eyal Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 4.  Th17 cytokines and vaccine-induced immunity.

Authors:  Yinyao Lin; Samantha R Slight; Shabaana A Khader
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

Review 5.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

6.  NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders.

Authors:  K Packwood; E Drewe; E Staples; D Webster; T Witte; J Litzman; W Egner; R Sargur; W Sewell; E Lopez-Granados; S L Seneviratne; R J Powell; B L Ferry; H M Chapel
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 7.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 8.  Induction and regulation of pathogenic Th17 cell responses in schistosomiasis.

Authors:  Bridget M Larkin; Patrick M Smith; Holly E Ponichtera; Mara G Shainheit; Laura I Rutitzky; Miguel J Stadecker
Journal:  Semin Immunopathol       Date:  2012-10-25       Impact factor: 9.623

Review 9.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

10.  Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine.

Authors:  Ivan Godinez; Manuela Raffatellu; Hiutung Chu; Tatiane A Paixão; Takeshi Haneda; Renato L Santos; Charles L Bevins; Renée M Tsolis; Andreas J Bäumler
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.